Torrent Pharma Sets Record Date for Amalgamation of J B Chemicals

Torrent Pharma Sets Record Date for Amalgamation of J B Chemicals

Torrent Pharma Sets Record Date for Amalgamation of J B Chemicals​

Torrent Pharmaceuticals Limited has determined the record date for its Scheme of Amalgamation with J B Chemicals & Pharmaceuticals Limited. The company fixed Friday, July 17, 2026, as the record date to identify shareholders of J B Chemicals who will be entitled to receive equity shares in Torrent Pharma based on the agreed share exchange ratio.

The amalgamation involves transferring J B Chemicals into Torrent Pharmaceuticals Limited. This move is part of a broader corporate restructuring process that has been sanctioned by the Hon'ble National Company Law Tribunal, Ahmedabad Bench.

In terms of the Scheme, the record date was set after consultation between both companies to determine the entitlement of shareholders under the established ratio.

The share exchange ratio specified in the Scheme dictates the following transaction details:

Original CompanyShares EntitledExchange Rate RatioAcquirer Company
J B Chemicals (Equity)100 shares (Face value Re. 1 each)5 to 100Torrent Pharma (Equity)
5 shares (Face value Rs. 5 each)

This action solidifies the transition of J B Chemicals into Torrent Pharmaceuticals Limited under the terms sanctioned by the NCLT.

TORNTPHARM Stock Price Movement​

Torrent Pharmaceuticals Limited shares gained in post-market trading today, closing at ₹4856.7 after the stock edged up 0.62%. The equity finished strong by achieving its 52-week high, finishing slightly shy of the intraday peak recorded at ₹4878.9.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top